Human Albumin Infusion in Critically Ill and Perioperative Patients: Narrative Rapid Review of Meta-Analyses from the Last Five Years
Journal of Clinical Medicine · 12.09.2023 · 12 (18) · 5919
DOI: 10.3390/jcm12185919 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.09.2023. Verfasst von Christian J Wiedermann. Beteiligte Einrichtung: Institute of General Practice and Public Health, Claudiana-College of Health Professions, 39100 Bolzano, Italy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Human albumin, a vital plasma protein with diverse molecular properties, has garnered interest for its therapeutic potential in various diseases, including critical illnesses. However, the efficacy of albumin infusion in critical care and its associated complications remains controversial. To address this, a review of recent meta-analyses was conducted to summarize the evidence pertaining to albumin use in critical illness.
Methods
Adhering to the rapid review approach, designed to provide a concise synthesis of existing evidence within a short timeframe, relevant meta-analyses published in the last five years were identified and analyzed. PubMed, Embase, and Cochrane databases of systematic reviews were searched using pre-defined search terms. Eligible studies included meta-analyses examining the association between albumin infusion and outcomes in critically ill and perioperative patients.
Results
Twelve meta-analyses were included in the review, covering diverse critical illnesses and perioperative scenarios such as sepsis, cardiothoracic surgery, and acute brain injury. The analyses revealed varying levels of evidence for the effects of albumin use on different outcomes, ranging from no significant associations to suggestive and convincing.
Conclusions
Albumin infusion stabilizes hemodynamic resuscitation endpoints, improves diuretic resistance, and has the potential to prevent hypotensive episodes during mechanical ventilation in hypoalbuminemic patients and improve the survival of patients with septic shock. However, caution is warranted due to the methodological limitations of the included studies. Further high-quality research is needed to validate these findings and inform clinical decision-making regarding albumin use in critical care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of General Practice and Public Health, Claudiana-College of Health Professions, 39100 Bolzano, Italy.
- Department of Public Health, Medical Decision Making and HTA, University of Health Sciences, Medical Informatics and Technology-Tyrol, 6060 Hall, Austria.
ORCID-Profile: Christian J Wiedermann
Zitieren
APA
Wiedermann, C. J. (2023). Human Albumin Infusion in Critically Ill and Perioperative Patients: Narrative Rapid Review of Meta-Analyses from the Last Five Years. Journal of Clinical Medicine, 12(18), 5919. https://doi.org/10.3390/jcm12185919
Vancouver
Wiedermann CJ. Human Albumin Infusion in Critically Ill and Perioperative Patients: Narrative Rapid Review of Meta-Analyses from the Last Five Years. Journal of Clinical Medicine. 2023;12(18):5919. doi:10.3390/jcm12185919
BibTeX
@article{Wiedermann2023,
author = {Wiedermann, Christian J},
title = {Human Albumin Infusion in Critically Ill and Perioperative Patients: Narrative Rapid Review of Meta-Analyses from the Last Five Years},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {18},
pages = {5919},
doi = {10.3390/jcm12185919}
}
EUVIMED